Minimolide F

CAS No. 1367351-41-4

Minimolide F( —— )

Catalog No. M29324 CAS No. 1367351-41-4

Minimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 218 Get Quote
5MG 335 Get Quote
10MG 537 Get Quote
25MG 842 Get Quote
50MG 1134 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Minimolide F
  • Note
    Research use only, not for human use.
  • Brief Description
    Minimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.
  • Description
    Minimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.
  • In Vitro
    Minimolide F has antiproliferative activity and can inhibit the CNE cell growth.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1367351-41-4
  • Formula Weight
    334.41
  • Molecular Formula
    C19H26O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@]12[C@]3([C@@]([C@@H](OC(C(C)C)=O)C1)([C@H](C)C[C@@]4([C@](C3)(C(=C)C(=O)O4)[H])[H])[H])O2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tesnatilimab

    Tesnatilimab is a potent humanized IgG4 monoclonal antibody that binds to the immune-activating receptor NKG2D.

  • 8-Azabicyclo-3.2.1-o...

    Reference standards.

  • IGF-I (24-41) TFA

    IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).IGF-I (24-41) (TFA) is amino acids 24 to 41 fragment of Insulin-like Growth Factor I (IGF-I).